Merck, the FDA, and the Vioxx Recall
페이지 정보
작성일 23-08-09 04:35
본문
Download : Merck, the FDA, and the Vioxx Recall.pptx
Download : Merck, the FDA, and the Vioxx Recall.pptx( 29 )
Merck, the FDA, and the Vioxx Recall
Merck, the FDA, and the Vioxx Recall , Merck, the FDA, and the Vioxx Recall기타레포트 , Merck the FDA and the Vioxx Recall
순서
레포트/기타
_SLIDE_1_
Merck, the FDA, and the Vioxx Recall
_SLIDE_2_
Introduction of Merck
In 2005 the company ranked fourth in sales, after Pfizer, Johnson & Johnson, and GlaxoSmithKline.
In assets and market value, it ranked fifth. However, Merck ranked first in profits, earning $7.33 billion on $30.78 billion in sales.
Company
Sales ($bil)
Profits ($bil)
Assets ($bil)
Market value($bil)
Pfizer
40.36
6.20
120.06
285.27
Johnson & Johnson
40.01
6.74
46.66
160.96
GlaxosmithKline
34.16
6.34
29.19
124.79
Merck
30.78
7.33
42.59
108.76
_SLIDE_3_
1851
Dr. Ernst Christian Friedrich Schering begins developing and selling pharmaceutical products in Berlin. Three years later, the company opened its first production facility.
1891
Merck&Co. opens its doors in United S…(생략(省略))
Merck, the FDA, and the Vioxx Recall
설명
Merck,the,FDA,and,the,Vioxx,Recall,기타,레포트
다.
